Triggering receptor expressed on myeloid cells 2 (TREM2), a transmembrane glycoprotein, is one of the most highly expressed receptors in microglia and has been widely considered to have an important role in AD pathogenesis (Qin et al., 2021). Here, TREM2 is linked to Alzheimer disease.